Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)
India flag India · Delayed Price · Currency is INR
71.39
+0.12 (0.17%)
At close: Feb 19, 2026

NSE:AAREYDRUGS Statistics

Total Valuation

NSE:AAREYDRUGS has a market cap or net worth of INR 2.04 billion. The enterprise value is 2.53 billion.

Market Cap 2.04B
Enterprise Value 2.53B

Important Dates

The last earnings date was Wednesday, February 11, 2026.

Earnings Date Feb 11, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 28.45M
Shares Outstanding n/a
Shares Change (YoY) +4.15%
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 14.98M

Valuation Ratios

The trailing PE ratio is 59.38.

PE Ratio 59.38
Forward PE n/a
PS Ratio 0.52
PB Ratio 1.37
P/TBV Ratio 1.37
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 73.58
EV / Sales 0.65
EV / EBITDA 100.98
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.38
Debt / EBITDA 22.76
Debt / FCF n/a
Interest Coverage 0.11

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 0.11%
Return on Capital Employed (ROCE) n/a
Weighted Average Cost of Capital (WACC) 6.36%
Revenue Per Employee 29.61M
Profits Per Employee 260,227
Employee Count 132
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, NSE:AAREYDRUGS has paid 23.24 million in taxes.

Income Tax 23.24M
Effective Tax Rate 40.36%

Stock Price Statistics

The stock price has increased by +66.08% in the last 52 weeks. The beta is 0.53, so NSE:AAREYDRUGS's price volatility has been lower than the market average.

Beta (5Y) 0.53
52-Week Price Change +66.08%
50-Day Moving Average 67.31
200-Day Moving Average 70.55
Relative Strength Index (RSI) 56.31
Average Volume (20 Days) 257,568

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NSE:AAREYDRUGS had revenue of INR 3.91 billion and earned 34.35 million in profits. Earnings per share was 1.19.

Revenue 3.91B
Gross Profit 65.46M
Operating Income 3.73M
Pretax Income 57.59M
Net Income 34.35M
EBITDA 25.03M
EBIT 3.73M
Earnings Per Share (EPS) 1.19
Full Income Statement

Balance Sheet

The company has 81.90 million in cash and 569.60 million in debt, with a net cash position of -487.70 million.

Cash & Cash Equivalents 81.90M
Total Debt 569.60M
Net Cash -487.70M
Net Cash Per Share n/a
Equity (Book Value) 1.49B
Book Value Per Share 53.06
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 1.67%, with operating and profit margins of 0.10% and 0.88%.

Gross Margin 1.67%
Operating Margin 0.10%
Pretax Margin 1.47%
Profit Margin 0.88%
EBITDA Margin 0.64%
EBIT Margin 0.10%
FCF Margin n/a

Dividends & Yields

NSE:AAREYDRUGS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -4.15%
Shareholder Yield -4.15%
Earnings Yield 1.68%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1